To complete the investigation, they also quantified mineralization process markers like bone morphogenetic protein 4 (BMP-4) and pentraxin-related protein PTX3 (PTX3), and their expression was also higher in presence of microcalcification compared with breast cancer lesions without microcalcifications [161]. The gene discussed is PTX3; the disease is breast carcinoma.